# A Post-Market Clinical Trial to Evaluate the Performance and Operation of the Brevera Breast Biopsy System

> **NCT03300206** · — · COMPLETED · sponsor: **Hologic, Inc.** · enrollment: 525 (actual)

## Conditions studied

- Breast Cancer Female

## Interventions

- **DEVICE:** Breast Biopsy

## Key facts

- **NCT ID:** NCT03300206
- **Lead sponsor:** Hologic, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-13
- **Primary completion:** 2019-03-19
- **Final completion:** 2019-03-19
- **Target enrollment:** 525 (ACTUAL)
- **Last updated:** 2024-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03300206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03300206, "A Post-Market Clinical Trial to Evaluate the Performance and Operation of the Brevera Breast Biopsy System". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03300206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*